Cargando…
Gene Editing of Hematopoietic Stem Cells: Hopes and Hurdles Toward Clinical Translation
In the field of hematology, gene therapies based on integrating vectors have reached outstanding results for a number of human diseases. With the advent of novel programmable nucleases, such as CRISPR/Cas9, it has been possible to expand the applications of gene therapy beyond semi-random gene addit...
Autores principales: | Ferrari, Samuele, Vavassori, Valentina, Canarutto, Daniele, Jacob, Aurelien, Castiello, Maria Carmina, Javed, Attya Omer, Genovese, Pietro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8525369/ https://www.ncbi.nlm.nih.gov/pubmed/34713250 http://dx.doi.org/10.3389/fgeed.2021.618378 |
Ejemplares similares
-
Mobilization-based chemotherapy-free engraftment of gene-edited human hematopoietic stem cells
por: Omer-Javed, Attya, et al.
Publicado: (2022) -
Genomic Engineering in Human Hematopoietic Stem Cells: Hype or Hope?
por: Klaver-Flores, Stefanie, et al.
Publicado: (2021) -
From Basic Biology to Patient Mutational Spectra of GATA2 Haploinsufficiencies: What Are the Mechanisms, Hurdles, and Prospects of Genome Editing for Treatment
por: Koyunlar, Cansu, et al.
Publicado: (2020) -
Editorial: Mutation-Specific Gene Editing for Blood Disorders
por: Lederer, Carsten Werner, et al.
Publicado: (2021) -
Hematopoietic stem and progenitors cells gene editing: Beyond blood disorders
por: Buffa, Valentina, et al.
Publicado: (2023)